论文部分内容阅读
目的探讨低分子肝素钙联合辛伐他汀治疗不稳定型心绞痛的疗效。方法将214例不稳定型心绞痛患者随机分为对照组(104例)和观察组(110例),对照组仅采用常规治疗,观察组在常规治疗基础上加用低分子肝素钙和辛伐他汀,观察两组疗效。结果观察组总有效率92.7%,对照组总有效率77.9%,两组疗效比较,差异有统计学意义(P<0.05);严重心血管事件发生率:观察组1.8%,对照组9.6%,两组比较,差异有统计学意义(P<0.05)。结论低分子肝素钙联合辛伐他汀治疗不稳定型心绞痛,能提高疗效,降低心血管事件发生率。
Objective To investigate the effect of low molecular weight heparin combined with simvastatin in the treatment of unstable angina pectoris. Methods 214 patients with unstable angina pectoris were randomly divided into control group (104 cases) and observation group (110 cases). The control group was treated with conventional therapy only. The observation group was given routine therapy with low molecular weight heparin and simvastatin , Observe the two groups curative effect. Results The total effective rate was 92.7% in the observation group and 77.9% in the control group, the difference was statistically significant (P <0.05). The incidence of serious cardiovascular events was 1.8% in the observation group and 9.6% in the control group, The difference between the two groups was statistically significant (P <0.05). Conclusion Low molecular weight heparin combined with simvastatin in patients with unstable angina pectoris can improve the curative effect and reduce the incidence of cardiovascular events.